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Abstract: We studied the effects of a C60 water suspension at 4 µg/mL (nC60) and the water 
soluble fullerenol C60(OH)24 at ﬁ  nal concentrations of 1 100 µg/mL on human umbilical vein 
endothelial cells (HUVECs) in culture. We found that a 24 hr treatment of HUVECs with 
C60(OH)24 at 100 µg/mL signiﬁ  cantly increased cell surface expression of ICAM-1(CD54) 
(67 ± 4% CD54+ cells vs. 19 ± 2 % CD54+ cells in control; p  0.001). In addition, this treat-
ment induced the expression of tissue factor (CD142) on HUVECs (54 ± 20% CD142+ cells vs 
4 ± 2% CD142+ cells in control; p = 0.008) and increased exposure of phosphatidylserine (PS) 
(29 ± 2% PS+ cells vs. 12 ± 5% PS+ cells in control; p  0.001). Analysis of cell cycle and DNA 
fragmentation (TUNEL) showed that both nC60 and C60(OH)24 caused G1 arrest of HUVECs and 
C60(OH)24 induced signiﬁ  cant apoptosis (21 ± 2% TUNEL+ cells at 100 µg/mL of C60(OH)24 vs. 
4 ± 2% TUNEL+ cells in control; p  0.001). We also demonstrated that both nC60 and C60(OH)24 
induced a rapid concentration dependent elevation of intracellular calcium [Ca2+]i. This could 
be inhibited by EGTA, suggesting that the source of [Ca2+]i in fullerene stimulated calcium 
ﬂ  ux is predominantly from the extracellular environment. In conclusion, fullerenol C60(OH)24 
had both pro-inﬂ  ammatory and pro-apoptotic effects on HUVECs, indicating possible adverse 
effects of fullerenes on the endothelium.
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Introduction
Carbon fullerenes have enormous practical potential in the ﬁ  eld of biomedical nano-
technology. Fullerenes and carbon nanotubes have already had a profound impact on 
the development of diagnostic biosensors, drug delivery nanosystems, and imaging 
nanoprobes for intravascular use. In addition, fullerenes can be used as components in 
a variety of plastics, including ﬁ  ltration membranes (Bosi et al 2003; Endo et al 2004; 
Bianco et al 2005; Sinha and Yeow 2005; Djordjevic et al 2006; Lacerda et al 2006; 
Polizu et al 2006; Harrison and Atala 2007). It has been reported that hydroxylated 
fullerene derivatives have potent antioxidant properties (Dugan et al 1996; Tsai et al 
1997; Huang et al 1998; Straface et al 1999; Wang et al 1999; Jin et al 2000). Fur-
thermore, the cytoprotective effects of fullerene derivatives in oxidative stress, mostly 
by free radical scavenging, have been demonstrated in different cell lines in vitro, 
and also on animal models, in vivo (Lin et al 1999; Tsao et al 1999; Lai et al 2000; 
Gharbi et al 2005; Daroczi et al 2006). It has been shown that fullerene derivatives 
have anti-viral and anti-bacterial properties. Also, their photodynamic cytotoxicity 
has been employed in experimental anti-tumor therapy and pathogen inactivation International Journal of Nanomedicine 2008:3(1) 60
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(Kasermann and Kempf 1997; Tabata et al 1997). However, 
several studies are raising safety concerns by showing possible 
cytotoxic effects of fullerenes and their derivatives (Sera et al 
1996; Chen et al 1998; Kamat et al 1998; Wolff et al 2000; 
Oberdorster 2004; Sayes et al 2005; Isakovic et al 2006; Zhu 
et al 2006). Although, it has been demonstrated that residual 
tetrahydrofuran (THF) used for the C60 fullerene solubilization 
substantially potentiates the toxicity of C60, the recent studies 
using the THF free water suspensions of fullerenes or water 
soluble polyhydroxylated fullerenols indicate their cytotoxic 
effects (Isakovic et al 2006; Zhu et al 2006). Despite the fact 
that many of the fullerene applications are based on intravas-
cular administration of these compounds, very little is known 
about the effects of fullerenes on endothelial cells (Yamawaki 
and Iwai 2006). Here we present a study investigating pro-
apoptotic and pro-inflammatory effects of water soluble 
fullerenol C60(OH)24 and a C60 fullerene water suspension 
(nC60) on cultured human umbilical vein endothelial cells.
Materials and methods
Fullerenes
The water soluble poly-hydroxylated fullerene derivative 
fullerenol C60(OH)24 (at ﬁ  nal concentrations of 1–100 µg/mL) 
from MER Corp., Tuscon, AZ was used for all experiments. In 
addition, the water nanocrystalline suspensions of insoluble C60 
(nC60) (C60 of 99.5% purity from SES Res., Houston, TX, USA) 
was prepared by continuous stirring 400 mg of C60 powder in 
400 mL of Milli-Q water for 2 weeks at room temperature. 
After stirring, the suspension was centrifuged twice at 4000 g 
for 20 minutes to remove larger aggregates of undissolved 
fullerene. The ﬁ  nal supernatant which contained 21 µg/mL 
of nC60 was collected, and stored at 4 °C. The concentration 
of nC60 was determined by extracting the C60 from the suspen-
sion by toluene and analyzing the absorbance at 336 nm, as 
described by Lyon et al (2006). In tissue culture experiments, 
the supernatant was diluted with the culture medium to a ﬁ  nal 
concentration of 4 µg/mL. As a control, the fullerene vehicle 
(Millli-Q H2O) was prepared in parallel by continuous stirring 
for 2 weeks at room temperature and manipulated the same 
way as nC60 suspension.
Analysis of hydrodynamic size 
distribution of fullerene particles using 
Dynamic Light Scattering (DLS)
The Malvern Zetasizer Nano ZS instrument (Southborough, 
MA) with a back scattering detector was used for measur-
ing the hydrodynamic size (diameter) in batch mode (no 
fractionation) at 25 °C in a low volume quartz cuvette. The 
relative particle volume is used as the size class for histo-
grams of the size distribution (the diameter is plotted on the 
abscissa and the particle volume on the ordinate). The average 
diameter (weighted by particle volume) of the largest peak 
in the volume distribution is reported as the hydrodynamic 
size, along with its standard deviation and the percentage 
of the total volume contained in the largest peak. The nC60 
sample concentration was 21 µg/mL as described in the stock 
preparation (see above). The hydroxylated C60 derivative 
(C60(OH)24) was weighed and dissolved in 10 mM NaCl to 
give a ﬁ  nal concentration of 2 mg/mL and ﬁ  ltered through a 
0.02µm ﬁ  lter (Anotop 10 Plus, Whatman International Ltd., 
Maidstone, England). A minimum of twelve measurements 
were made per sample.
Human umbilical vein endothelial cells 
(HUVECs)
HUVECs (2nd passage) from Cambrex (Walkersville, MD), 
were cultured in either 6 or 24 well plates (Becton Dickinson 
Labware, Franklin Lakes, NJ) with EGM-2 media containing 
2% fetal bovine serum and supplements (Cambrex). Cells 
were used for experiments when they reached 80%–90% 
conﬂ  uence (∼48 hrs in culture). HUVECs were washed and 
incubated for 24 hrs at 37 °C with fullerenol C60(OH)24 or 
fullerene nC60 in water diluted one to ﬁ  ve with the EGM-2 
medium. After incubation, cells were harvested with 20 mM 
HEPES buffer with 100 mM NaCl, 0.5% BSA and 10 mM 
EDTA, pH 7.4. After harvesting, the cells were centrifuged 
(300 g for 5 min), washed with Hanks’ balanced salt solu-
tion with 0.35% bovine serum albumin (HBSS/BSA) and 
used for analysis.
Antibodies
Cy-Chrome conjugated anti-human monoclonal antibody 
(mAb) to CD54 (ICAM-1, clone HA58), phycoerythrin-
conjugated (PE) anti-human mAb to CD142 (tissue factor, 
clone HTF-1), isotype matched controls, annexin V (FITC-
conjugated), and an APO-BRDU kit were purchased from 
BD Pharmingen (San Diego, CA). All antibodies were titrated 
to ensure saturating concentrations.
Labeling of endothelial cells
Approximately 105 cells were resuspended in 50 µL of 
HBSS/BSA and incubated with saturating concentration of 
the mAbs or annexin V. Non-labeled cells and cells incubated 
with either relevant isotype controls or with annexin V in 
the presence of 20 mM EDTA were prepared as controls. International Journal of Nanomedicine 2008:3(1) 61
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After 20 min incubation at room temperature, the suspension 
of labeled cells was diluted with 2 mL of HBSS/BSA and 
centrifuged (300 × g for 5 min). Sedimented cells were 
resuspended in 0.5 mL of HBSS/BSA and analyzed using 
ﬂ  ow cytometry.
Flow cytometry of endothelial cells
Cell samples were analyzed as described previously (Simak 
et al 2002; Simak, Holada, and Vostal et al 2002). Brieﬂ  y, 
a FACSCalibur ﬂ  ow cytometer (Becton Dickinson, San 
Diego, CA, USA) equipped with CELLQuest software, 
with forward scatter (FSC) and side scatter (SSC) in linear 
mode was used. Populations of intact cells were gated 
according to their light-scattering characteristics in order 
to exclude debris, and 10,000 gated cells were analyzed for 
each sample. The total percentage (%) of CD54+, CD142+, 
and PS+ (annexin V-binding) cells was evaluated. Apop-
tosis (TUNEL) was analyzed using the APO-BRDU kit 
following the manufacturer’s instructions (BD Pharmin-
gen, San Diego, CA). In addition, cell cycle analysis was 
performed using ModFit software (Verity Software House, 
Topsham, ME).
Intracellular free Ca2+ assay
The acute effect of fullerenes on intracellular free Ca2+ 
concentration was studied in HUVEC loaded with a Ca2+- 
sensitive probe (FURA-2AM). Changes in ﬂ  uorescence in 
individual cells (n = 100) were monitored at 340 nm and 
380 nm excitation (the rate of data capture was 170/min) 
using a Nikon inverted epi-ﬂ  uorescence/phase microscope 
equipped with a low-light level integrating CCD camera 
with a microphotometer assembly (InCyt I/P-2 TM Imag-
ing and Photometry System, Intracellular Imaging Inc., 
Cincinnati, OH). Intracellular [Ca2+]i in real time was 
calculated from the ratio of emission detected at 510 nm 
at two excitation wavelengths (340 nm and 380 nm) and 
by comparison to a standard curve established for these 
settings using buffers of known free [Ca2+] with the InCyt 
Im2 software.
Statistical analyses
Results are presented as means ± standard deviations (SD). 
Kruskal-Wallis One Way Analysis of Variance on Ranks and 
multiple comparisons using Student-Newman-Keuls method 
or Dunett’s method was used where appropriate (SPSS 12; 
SPSS, Chicago, IL). A value of p  0.05 was considered 
statistically signiﬁ  cant.
Results
Hydrodynamic size distribution of 
fullerene particles in nC60 and C60(OH)24 
preparations
The mean size distribution by volume and the mean 
hydrodynamic diameter of nC60 and C60(OH)24 are shown 
in Figure 1. Based on the size distributions of particles 
present in the nC60 water suspension (Figure 1A), the major 
water soluble component is about 224 nm in size. The small 
peak at about 5000 nm corresponds to approximately 2% 
of the total particle volume, and may be due to aggregates. 
Since unmodiﬁ  ed nC60 is not immediately water soluble, 
we stirred C60 in water for two weeks, which resulted in 
a nanocrystalline suspension of stable aggregates (nC60). 
nC60 refers to an unknown number ‘n’ of C60 molecules 
agglomerating to form the suspension. The formed clus-
ters contain unmodiﬁ  ed C60 in their centers, surrounded 
by partially hydroxylated C60 on the outside (Fortner et al 
2005). In contrast, the fullerenol C60(OH)24 is very soluble in 
water. Based on its size distribution by volume (Figure 1B), 
only one peak at 4.3 nm was observed, as expected for the 
hydroxylated C60 derivative.
High dose fullerenol C60(OH)24 induced 
elevated HUVEC surface expression of 
ICAM-1 (CD54), tissue factor (CD142), 
and phosphatidylserine (PS)
HUVECs were cultured for 24 hrs with different concentra-
tions of fullerenol C60(OH)24, (1, 10, 50, and 100 µg/mL), 
fullerene nC60 at 4 µg/mL, or with the vehicle. Flow 
cytometry was used to analyze the difference in expression 
of several surface markers. Figure 2 shows that the 24 hr 
treatment of HUVECs with 100 µg/mL C60(OH)24 signiﬁ  -
cantly increased cell surface expression of ICAM-1(CD54) 
(67 ± 4% CD54+cells vs 19 ± 2% CD54+ cells in control; 
p  0.001). This treatment also induced expression of tis-
sue factor (CD142) on HUVECs (54 ± 20% CD142+ cells 
vs 4 ± 2% CD142+ cells in control; p = 0.008). In addition, 
an increase in exposed phosphatidylserine (PS, detected 
by Annexin V) (29 ± 2% PS+ cells vs 12 ± 5% PS+ cells in 
control; p  0.001) was identiﬁ  ed. However, treating the 
HUVECs with lower concentrations of fullerenol C60(OH)24 
or nC60 at 4 µg/mL did not induce a signiﬁ  cant increase of 
surface expression of CD54, CD142 or PS.International Journal of Nanomedicine 2008:3(1) 62
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Both fullerene C60 and fullerenol 
C60(OH)24 induced G1 arrest and a high 
dose of fullerenol induced signiﬁ  cant 
apoptosis (TUNEL) in HUVECs
Analysis of the cell cycle by ﬂ  ow cytometry showed that both nC60 
at 4 µg/mL and C60(OH)24 at concentrations 10 - 100 µg/mL caused 
signiﬁ  cant G1 arrest in HUVECs after 24 hours of treatment 
(Figure 3). In addition, fullerenol C60(OH)24 at 100 µg/mL induced 
signiﬁ  cant apoptosis after 24 hours treatment of HUVECs, as 
compared to control cells treated with the vehicle (21 ± 2% 
TUNEL+ cells at 100 µg/mL of C60(OH)24 vs. 4 ± 2% TUNEL+ 
cells in control; p  0.001) (Figure 4). Treating the HUVECs with 
lower concentrations of fullerenol C60(OH)24 or nC60 at 4 µg/mL 
did not induce signiﬁ  cant increase of TUNEL+ cells.
Both fullerene nC60 and fullerenol 
C60(OH)24 induced acute Ca2+ inﬂ  ux 
in HUVECs
The acute effect of fullerenes on intracellular free Ca2+ 
concentration [Ca2+]i was studied, using a ratio ﬂ  uorometry 
in HUVECs. Cells were loaded with a Ca2+-sensitive probe 
FURA-2AM. We demonstrated that both nC60 and C60(OH)24 
induced a rapid concentration dependent elevation of [Ca2+]i. 
nC60 caused a continuous increase in [Ca2+]i and was about 
ten times more potent compared to C60(OH)24 (Figure 5). 
This activity of both C60(OH)24 and nC60 could be inhibited 
by EGTA, suggesting that the source of [Ca2+]i in fullerene 
stimulated calcium ﬂ  ux is predominantly from the extracel-
lular environment.
Figure 1 Hydrodynamic size distribution of fullerene particles in nC60 and C60(OH)24 preparations. Shown are the volume distributions (each line is the average of at least 
twelve measurements per sample) of the nC60 water suspension (A), and C60(OH)24 in 10mM NaCl (B).
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Figure 2 Flow cytometric analysis of HUVECs treated for 24 hrs with fullerenol C60 (OH)24 (100 µg/mL) or the vehicle (CTRL). Data are presented as means + SD (n = 3).
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Figure 5 Analysis of C60(OH)24 and nC60 induced intracellular Ca2+ increase (∆[Ca2+]i) in HUVECs: (A) The upper tracing shows the time course of C60(OH)24-induced ∆[Ca2+]i 
in a representative cell. The lower tracing shows a time course in a representative cell in a Ca2+ free solution (containing 1 mM EGTA).  Arrows indicate when C60(OH)24 (ﬁ  nal 
conc. 80 µg/mL) was added. There was no response observed when the fullerenol vehicle was added (not shown). (B) A dose-response curves for the effect of C60(OH)24 on 
∆[Ca2+]i and the percentage of cells responded. Mean values of 30 cells ± SD are shown. (C) The upper tracing shows the time course of nC60-induced ∆[Ca2+]i in a represen-
tative cell. The lower tracing shows a time course in a representative cell in a Ca2+ free solution (containing 1 mM EGTA). Arrows indicate when nC60 (ﬁ  nal conc. 10 µg/mL) 
was added. There was no response observed when the nC60 vehicle was added (not shown). (D) A dose-response curves for the effect of nC60 on ∆[Ca2+]i and the percentage 
of cells responded. Mean values of 30 cells ± SD are shown.
Discussion
Our study showed that fullerenol induced pro-inﬂ  ammatory 
activation of cultured HUVECs, which was indicated 
by the increase of CD54 (ICAM-1) and CD142 (TF) 
surface expression. The intercellular adhesive molecule 1 
(ICAM-1), also referred to as CD54, is an adhesive receptor 
of the immunoglobulin gene superfamily. It is constitutively 
expressed at low levels on most types of vascular endothe-
lial cells, and is highly upregulated on pro-inﬂ  ammatory 
cytokine activated endothelium (Mutin et al 1997a). Tissue 
factor (TF), also referred to as CD142, is a cellular receptor 
and cofactor of activated factor VIIa. Tissue factor initiates 
activation of the plasma coagulation system, which leads 
to the generation of thrombin activity (Steffel et al 2006). 
Although functional TF is not exposed in signiﬁ  cant levels 
on resting HUVECs, its expression is greatly increased after 
stimulation with pro-inﬂ  ammatory cytokines and some 
other stimuli, similarly to ICAM-1 (Mutin et al 1997b). In 
addition, the observed increased exposure of phosphatidyl-
serine (PS) on the plasma membrane of HUVECs indicates 
a disturbance of the membrane asymmetry, likely due to 
pro-apoptotic stimulation or other types of cell activation. 
Although the exposure of PS on cells incubated with the 
fullerenol vehicle (the Milli-Q water) was higher than 
expected, the difference in PS-surface exposure between 
vehicle- treated and fullerenol-treated cells was highly sig-
niﬁ  cant (P  0.001). PS is an essential cofactor for activa-
tion complexes in the plasma coagulation system. Also, it 
is a signaling molecule for phagocytes (Zwaal et al 2005). 
Thus, our results show that the phenotype of endothelial 
cells treated with fullerenol become pro-inﬂ  ammatory and 
pro-coagulant. It is important to further investigate whether 
fullerenes exhibit similar effects on the endothelium in vivo 
in animal models.
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Our cell cycle analysis showed that both nC60 and C60(OH)24 
induced G1 arrest in HUVECs. Polyhydroxylated fullerenol-1 
was reported to inhibit the proliferative responses in a variety of 
cells, including smooth muscle cells and human lymphocytes, 
in a concentration dependent manner. The tested concentration 
range was of 10-6 to 10-2 M, which corresponds to approximately 
1 µg/mL to 10 mg/mL. It was also shown that fullerenol inhibited 
cytosolic protein kinase C activity. Therefore, it was suggested 
that the anti-proliferative effect of fullerenol-1 on vascular 
smooth muscle cells may partly be mediated through the inhibi-
tion of protein tyrosine kinase (Lu et al 1998).
We found that C60(OH)24 induced apoptosis in HUVECs. 
This was clearly detected by TUNEL assay, which is a com-
mon method for detecting DNA fragmentation. In addition, 
the observed increase in PS exposure of fullerenol treated cells 
can be considered as supporting evidence of pro-apoptotic 
activation of HUVECs. Our ﬁ  nding contradicts the results of 
a recent study by Yamawaki and Iwai (Yamawaki and Iwai 
2006). These authors concluded that fullerenol did not cause 
apoptosis based on the failure to demonstrate cleavage of cas-
pase 3 and PARP. However, their study showed autophagic 
cell death in fullerenol treated HUVECs. We may therefore 
speculate that both apoptotic and autophagic cell death may 
occur in fullerenol treated endothelium.
To investigate a possible mechanism of fullerene action 
on endothelium, we demonstrated that both nC60 and 
C60(OH)24 induced inﬂ  ux of extracellular Ca2+ in HUVECs. 
This suggests that fullerenes may either activate some of the 
Ca2+ channels on the cell membrane, or that they may create 
new channels/pores to facilitate Ca2+ inﬂ  ux, or both. In either 
case, it results in an increase in intracellular Ca2+, which may 
induce activation and/or apoptotic changes of the cells.
In conclusion, the results of this pilot study show pos-
sible adverse effects of fullerenes on the endothelium. The 
hydroxyfullerene C60(OH)24, had both pro-inﬂ  ammatory and 
pro-apoptotic effects on endothelial cells. In addition, cell 
cycle arrest and increase of intracellular Ca2+ was observed 
in cells treated with hydroxyfullerene C60(OH)24 and also 
with a low concentration of nC60. With the wide potential 
applications of fullerenes in mind, the safety hazards of these 
materials need to be thoroughly evaluated. We suggest that 
additional in depth studies should be performed to investigate 
possible adverse effects of fullerenes on the cardiovascular 
system in exposed populations.
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